Healthcare investor Third Rock Ventures has closed on just over $1.1 billion from 65 investors for its sixth fund, Third Rock Ventures VI, according to a regulatory filing.
The of Boston-based firm, which also has an office in San Francisco, previously raised $770 million for its fifth fund in June 2019.
Founded in 2007, Third Rock invests in healthcare, biotech and pharma companies.
The minimum investment for the new fund was $500,000, with a first sale occurring on May 26, 2022, according to the filing.
The filing shows that the general partnership of the new fund, TRV GP VI LLC, is comprised of eight managers: Abbie Celniker, Neil Exter, Kevin Gillis, Reid Huber, David Kaufman, Cary Pfeffer, Robert Tepper and Jeffrey Tong.
Third Rock did not disclose the names of its investors, but Venture Capital Journal’s fund database shows that LPs in its previous fund included Pritzker Traubert Foundation and the Grantham Foundation, while investors in Fund IV included Pritzker, Grantham and Laborers’ District Council and Contractors’ Pension Fund of Ohio.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: